Probing the Binding of Valacyclovir Hydrochloride to the Human Serum Albumin

Authors

  • Navid Soltani Rad Department of Chemistry, Shiraz University of Technology, Shiraz 71555-313, Iran
  • Negar Parvizi Department of Chemistry, Shiraz University of Technology, Shiraz, 71555-313
  • Reza Yousefi Protein Chemistry Laboratory, Department of Biology, Shiraz University, Shiraz 71454, Iran
  • Somayeh Behrouz Department of Chemistry, Shiraz University of Technology, Shiraz 71555-313, Iran
Abstract:

UV-visible and Fluorescence spectroscopic methods were employed to study the interaction of human serum albumin (HSA) with Valacyclovir Hydrochloride. Additionally, molecular dynamics and molecular docking simulations were used to visualize and specify the binding site of Valacyclovir Hydrochloride. The Stern-Volmer and van't Hoff equations along with spectroscopic observations, were used to determine the binding and thermodynamic parameters. Overall obtained results revealed the presence of dynamic type of quenching mechanism in binding of Valacyclovir Hydrochloride to HSA, while the interaction was found to be entropy driven at domain III of HSA. Analyzing the protein ligand interactions with LIGPLOT, confirmed the dominance of hydrophobic interactions, while the hydrogen bonding interactions play the minor role.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Fluoxetin Competes with Cortisol for Binding to Human Serum Albumin

Human serum albumin (HSA) is an important protein that carries variety of substances like some hormones and drugs in blood. Pharmacological studies of the interaction of many drugs and HSA are reported during several decades, specially recently years. Interaction of cortisol and fluoxetine hydrochloride (FLX) (as a common anti-stress drug) with HSA (as their carrier in blood) has been studied s...

full text

Fluoxetin Competes with Cortisol for Binding to Human Serum Albumin

Human serum albumin (HSA) is an important protein that carries variety of substances like some hormones and drugs in blood. Pharmacological studies of the interaction of many drugs and HSA are reported during several decades, specially recently years. Interaction of cortisol and fluoxetine hydrochloride (FLX) (as a common anti-stress drug) with HSA (as their carrier in blood) has been studied s...

full text

Co-amoxiclav Effects on the Structural and Binding Properties of Human Serum Albumin

Human serum albumin (HSA) is the most abundant plasma protein in the human body. HSA plays an important role in drug transport and metabolism. This protein has a high affinity to a very wide range of materials, including metals such as Cu2+ and Zn2+, fatty acids, amino acids and metabolites such as bilirubin and many drug compounds. In this study, we investigated the effects of co-amoxiclav, as...

full text

Molecular dynamics simulation and docking studies on the binding properties of several anticancer drugs to human serum albumin

Disposition and transportation of anticancer drugs by human serum albumin (HSA) affects their bioavailability, distribution and elimination. In this study, the interaction of a set of anticancer drugs with HSA was investigated by molecular dynamics and molecular docking simulations. The drugs' activities were analyzed according to their docking scores, binding sites and structural descriptors. ...

full text

Co-amoxiclav Effects on the Structural and Binding Properties of Human Serum Albumin

Human serum albumin (HSA) is the most abundant plasma protein in the human body. HSA plays an important role in drug transport and metabolism. This protein has a high affinity to a very wide range of materials, including metals such as Cu2+ and Zn2+, fatty acids, amino acids and metabolites such as bilirubin and many drug compounds. In this study, we investigated the effects of co-amoxiclav, as...

full text

Probing of the Interaction Between Human Serum Albumin and A New Synthesized Pd(II) Complex Using Spectroscopic Methods

Human serum albumin (HSA) is an abundant, multifunctional and nonglycosylated negatively charged plasma protein. HSA ascribed ligand-binding and transport properties, antioxidant functions and enzymatic activities. In the present study, the interaction and side effects of a new designed anti-cancer compound (1,10-phenanthroline butyl dithiocarbamato palladium(II) nitrate) on HSA have been inves...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 4

pages  751- 764

publication date 2019-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023